
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1053 | 931 | 1053 | 1024 | 1242 | 1541 |
Fund Return | 5.32% | -6.95% | 5.32% | 0.78% | 4.43% | 4.42% |
Place in category | 264 | 189 | 264 | 291 | 306 | 304 |
% in Category | 36 | 27 | 36 | 53 | 54 | 75 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GuidePath Growth Allocation Svc | 1.33B | 1.23 | 8.12 | 8.16 | ||
GuideMark Large Cap Core Service | 715.43M | 0.33 | 10.60 | 11.31 | ||
GuidePath Tactical Allocation Svc | 641.54M | 0.61 | 10.38 | 6.91 | ||
GuidePath Conservative Allocation | 557.8M | 3.07 | 4.11 | 4.03 | ||
GuideMark Emerging Markets Service | 44.85M | 8.76 | -0.37 | 4.14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 209.79B | 5.17 | 4.34 | 4.95 | ||
Vanguard Total Intl Stock Index Adm | 76.18B | 5.24 | 4.42 | 5.02 | ||
Fidelity International Index Inst | 55.99B | 8.06 | 6.85 | 5.50 | ||
Fidelity Series Global ex US Index | 52.88B | 6.06 | 4.88 | 4.92 | ||
Strategic Advisers International I | 47.55B | 7.61 | 6.47 | 6.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
iShares MSCI EAFE | US4642874659 | 2.69 | 81.85 | +0.15% | |
Novo Nordisk B | DK0062498333 | 1.73 | 479.0 | +1.96% | |
Novartis | CH0012005267 | 1.01 | 98.42 | +0.59% | |
AstraZeneca | GB0009895292 | 1.00 | 11,366.0 | +1.00% | |
ASML Holding | NL0010273215 | 0.99 | 619.70 | +2.26% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review